Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Remicade Biosimilar Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Remicade Biosimilar Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 100mg/10ml
      • 1.3.3 500mg/50ml
    • 1.4 Market Segment by Application
      • 1.4.1 Global Remicade Biosimilar Market Share by Application (2019-2025)
      • 1.4.2 Blood Disorders
      • 1.4.3 Oncology Diseases
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Remicade Biosimilar Market Size
      • 2.1.1 Global Remicade Biosimilar Revenue 2014-2025
      • 2.1.2 Global Remicade Biosimilar Sales 2014-2025
    • 2.2 Remicade Biosimilar Growth Rate by Regions
      • 2.2.1 Global Remicade Biosimilar Sales by Regions 2014-2019
      • 2.2.2 Global Remicade Biosimilar Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Remicade Biosimilar Sales by Manufacturers
      • 3.1.1 Remicade Biosimilar Sales by Manufacturers 2014-2019
      • 3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Remicade Biosimilar Revenue by Manufacturers (2014-2019)
      • 3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI)
    • 3.3 Remicade Biosimilar Price by Manufacturers
    • 3.4 Key Manufacturers Remicade Biosimilar Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Remicade Biosimilar Market
    • 3.6 Key Manufacturers Remicade Biosimilar Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 100mg/10ml Sales and Revenue (2014-2019)
      • 4.1.2 500mg/50ml Sales and Revenue (2014-2019)
    • 4.2 Global Remicade Biosimilar Sales Market Share by Type
    • 4.3 Global Remicade Biosimilar Revenue Market Share by Type
    • 4.4 Remicade Biosimilar Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Remicade Biosimilar Sales by Application

    6 United States

    • 6.1 United States Remicade Biosimilar Breakdown Data by Company
    • 6.2 United States Remicade Biosimilar Breakdown Data by Type
    • 6.3 United States Remicade Biosimilar Breakdown Data by Application

    7 European Union

    • 7.1 European Union Remicade Biosimilar Breakdown Data by Company
    • 7.2 European Union Remicade Biosimilar Breakdown Data by Type
    • 7.3 European Union Remicade Biosimilar Breakdown Data by Application

    8 China

    • 8.1 China Remicade Biosimilar Breakdown Data by Company
    • 8.2 China Remicade Biosimilar Breakdown Data by Type
    • 8.3 China Remicade Biosimilar Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Remicade Biosimilar Breakdown Data by Company
    • 9.2 Rest of World Remicade Biosimilar Breakdown Data by Type
    • 9.3 Rest of World Remicade Biosimilar Breakdown Data by Application
    • 9.4 Rest of World Remicade Biosimilar Breakdown Data by Countries
      • 9.4.1 Rest of World Remicade Biosimilar Sales by Countries
      • 9.4.2 Rest of World Remicade Biosimilar Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Synthon Pharmaceuticals
      • 10.1.1 Synthon Pharmaceuticals Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.1.4 Remicade Biosimilar Product Introduction
      • 10.1.5 Synthon Pharmaceuticals Recent Development
    • 10.2 LG Life Sciences
      • 10.2.1 LG Life Sciences Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.2.4 Remicade Biosimilar Product Introduction
      • 10.2.5 LG Life Sciences Recent Development
    • 10.3 Novartis (Sandoz)
      • 10.3.1 Novartis (Sandoz) Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.3.4 Remicade Biosimilar Product Introduction
      • 10.3.5 Novartis (Sandoz) Recent Development
    • 10.4 Celltrion
      • 10.4.1 Celltrion Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.4.4 Remicade Biosimilar Product Introduction
      • 10.4.5 Celltrion Recent Development
    • 10.5 Biocon
      • 10.5.1 Biocon Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.5.4 Remicade Biosimilar Product Introduction
      • 10.5.5 Biocon Recent Development
    • 10.6 Hospira
      • 10.6.1 Hospira Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.6.4 Remicade Biosimilar Product Introduction
      • 10.6.5 Hospira Recent Development
    • 10.7 Merck Serono (Merck Group)
      • 10.7.1 Merck Serono (Merck Group) Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.7.4 Remicade Biosimilar Product Introduction
      • 10.7.5 Merck Serono (Merck Group) Recent Development
    • 10.8 Biogen idec Inc.
      • 10.8.1 Biogen idec Inc. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.8.4 Remicade Biosimilar Product Introduction
      • 10.8.5 Biogen idec Inc. Recent Development
    • 10.9 Genentech (Roche Group)
      • 10.9.1 Genentech (Roche Group) Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Remicade Biosimilar
      • 10.9.4 Remicade Biosimilar Product Introduction
      • 10.9.5 Genentech (Roche Group) Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Remicade Biosimilar Sales Channels
      • 11.2.2 Remicade Biosimilar Distributors
    • 11.3 Remicade Biosimilar Customers

    12 Market Forecast

    • 12.1 Global Remicade Biosimilar Sales and Revenue Forecast 2019-2025
    • 12.2 Global Remicade Biosimilar Sales Forecast by Type
    • 12.3 Global Remicade Biosimilar Sales Forecast by Application
    • 12.4 Remicade Biosimilar Forecast by Regions
      • 12.4.1 Global Remicade Biosimilar Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Remicade Biosimilar Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 
      In 2019, the market size of Remicade Biosimilar is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Remicade Biosimilar.

      This report studies the global market size of Remicade Biosimilar, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Remicade Biosimilar sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Synthon Pharmaceuticals
      LG Life Sciences
      Novartis (Sandoz)
      Celltrion
      Biocon
      Hospira
      Merck Serono (Merck Group)
      Biogen idec Inc.
      Genentech (Roche Group)

      Market Segment by Product Type
      100mg/10ml
      500mg/50ml

      Market Segment by Application
      Blood Disorders
      Oncology Diseases

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Remicade Biosimilar status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Remicade Biosimilar manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Remicade Biosimilar are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now